Cyclic Disulfide Liposomes for Membrane Functionalization and Cellular Delivery
- 6 July 2022
- journal article
- research article
- Published by Wiley in Chemistry – A European Journal
- Vol. 28 (45) , e202201164
Abstract
Liposomes are effective therapeutic delivery nanocarriers due to their ability to encapsulate and enhance the pharmacokinetic properties of a wide range of therapeutics. Two primary areas in which improvement is needed for liposomal drug delivery is to enhance the ability to infiltrate cells and to facilitate derivatization of the liposome surface. Herein, we report a liposome platform incorporating a cyclic disulfide lipid (CDL) for the dual purpose of enhancing cell entry and functionalizing the liposome membrane through thiol‐disulfide exchange. In order to accomplish this, CDL‐1 and CDL‐2, composed of lipoic acid (LA) or asparagusic acid (AA) appended to a lipid scaffold, were designed and synthesized. A fluorescence‐based microplate immobilization assay was implemented to show that these compounds enable convenient membrane decoration through reaction with thiol‐functionalized small molecules. Additionally, fluorescence microscopy experiments indicated dramatic enhancements in cellular delivery when CDLs were incorporated within liposomes. These results demonstrate that multifunctional CDLs serve as an exciting liposome system for surface decoration and enhanced cellular delivery.Keywords
Funding Information
- Directorate for Mathematical and Physical Sciences (DMR-1807689)
This publication has 41 references indexed in Scilit:
- Trigger release liposome systems: local and remote controlled delivery?Journal of Microencapsulation, 2011
- Disulfide Bond That Constrains the HIV-1 gp120 V3 Domain Is Cleaved by ThioredoxinJournal of Biological Chemistry, 2010
- Enzyme-triggered nanomedicine: Drug release strategies in cancer therapy (Invited Review)Molecular Membrane Biology, 2010
- Microplate-Based Analysis of Protein−Membrane Binding Interactions via Immobilization of Whole Liposomes Containing a Biotinylated AnchorBioconjugate Chemistry, 2009
- Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to ClinicCritical Reviews™ in Therapeutic Drug Carrier Systems, 2009
- Redox-Triggered Contents Release from LiposomesJournal of the American Chemical Society, 2008
- pH-Sensitive liposomes-principle and application in cancer therapyJournal of Pharmacy and Pharmacology, 2007
- Keynote review: Progress in targeting HIV-1 entryDrug Discovery Today, 2005
- The tumor blood vessel as an ideal target for macromolecular anticancer agentsJournal of Controlled Release, 1992
- Synthesis of carboxyacyl derivatives of phosphatidylethanolamine and use as an efficient method for conjugation of protein to liposomesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1986